FREE Event "Neurogenic Bowel Management – A Continuum of Care" (In Person & Virtual Experience)

 The purpose and opportunity for the learner from this 180-minute presentation is to provide a better understanding of current information on the best practices based on research and a literature review of neurogenic bowel management.  Give the learner a better understanding of the bowel care journey provided by an SCI individual who has a C3/4 level of injury. The program will focus on maximizing the effectiveness and understanding of bowel care for patients with SCI, MS, Parkinson’s and Spina Bifida

After the presentation the learner will be able to: 

Part 1 -Overview of NBD in SCI, MS and Spina Bifida

1. Know the history of Non-traumatic spinal cord
2. Understand who is affected by neurogenic bowel dysfunction
3. Understand the role of the vagus nerve in regulating bowels
4. Understand levels of injury by bowel type

Part 2 - Neuro Tube Defect – Spina Bifida

1. Distinguish between the most common Neuro Tube Defects
2. Understand the current best practices for bowel care in Spina Bifida
3. Understand the bowel care challenges faced by Spina Bifida patients and the need for social and community support

Part 3 – SCI

1. Discuss the Characteristics of NBD in SCI
2. Understand the complications of NBD and complications during rehab
3. Assess Secondary Health Problems
4. Communicate goals for achieving a better QOL in SCI

Part 3 – Parkinson’s Disease

1.Know Parkinson’s Disease signs, symptoms and causes

1. Understand How Parkinson’s Disease affects the GI tract
2. Discuss Constipation and Parkinson’s Disease
3. Recognize Aging with Parkinson’s Disease

Part 4 – MS

1. Understand the social, physical, and economic impact of Bowel Dysfunction in MS
2. Explain the challenges of the MS patients once they are home

Part 5 – AD in SCI and MS

1. Explain AD, the risk and causes
2. Discuss a case study of an MS patient with AD

Part 6 – Neurogenic Bowel Dysfunction Treatment

1. Identify the treatment for Neurogenic bowel in SCI, MS, and Spina Bifida
2. Compare four rectal formulations in an evidence-based study
3. Understand the morphological in the mucosal lining as a result of bisacodyl